{
    "xml": "<topic id=\"PHP34582\" outputclass=\"drugClass\" rev=\"1.14\" type=\"drugClass\" namespace=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\" basename=\"anti-lymphocyte-monoclonal-antibodies\" title=\"ANTI-LYMPHOCYTE MONOCLONAL ANTIBODIES\">\n<title>ANTI-LYMPHOCYTE MONOCLONAL ANTIBODIES</title>\n<topic id=\"PHP55883\" outputclass=\"drugAction\" rev=\"1.7\" parent=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>The anti-lymphocyte monoclonal antibodies cause lysis of B lymphocytes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55919\" outputclass=\"importantSafetyInformation\" rev=\"1.23\" parent=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p>All anti-lymphocyte monoclonal antibodies should be given under the supervision of an experienced specialist, in an environment where full resuscitation facilities are immediately available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55567\" outputclass=\"sideEffects\" rev=\"1.37\" parent=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Allergic reactions</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">chills</ph>; <ph outputclass=\"sideEffect\">cytokine release syndrome</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">tumour pain</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cardiac events</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Infusion-related side-effects</p>\n<p>In rare cases infusion reactions may be fatal.</p>\n<p>Infusion-related side-effects occur predominantly during the first infusion. Patients should receive premedication before administration of anti-lymphocyte monoclonal antibodies to reduce these effects&#8212;consult product literature for details of individual regimens.</p>\n<p>The infusion may have to be stopped temporarily and the infusion-related effects treated&#8212;consult product literature for appropriate management.</p>\n<p>Evidence of pulmonary infiltration and features of tumour lysis syndrome should be sought if infusion-related effects occur.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Cytokine release syndrome</p>\n<p>Fatalities following <b>severe</b> cytokine release syndrome (characterised by severe dyspnoea) and associated with features of tumour lysis syndrome have occurred after infusions of anti-lymphocyte monoclonal antibodies. Patients with a high tumour burden as well as those with pulmonary insufficiency or infiltration are at increased risk and should be monitored <b>very closely</b> (and a slower rate of infusion considered).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55589\" outputclass=\"preTreatmentScreening\" rev=\"1.9\" parent=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\">\n<title>Pre-treatment screening</title>\n<body>\n<section>\n<sectiondiv>\n<p>All patients should be screened for hepatitis B before treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55443\" outputclass=\"monitoringRequirements\" parent=\"/drug-classes/anti-lymphocyte-monoclonal-antibodies\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Patients should also be monitored for cytopenias&#8212;consult product literature for specific recommendations.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugClasses\" href=\"#drugClasses\" title=\"Drug classes\" namespace=\"/drug-classes\">Drug classes</xref>\n</parents>\n<drugs>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP5660\" title=\"OFATUMUMAB\" namespace=\"/drugs/ofatumumab\">OFATUMUMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP5662\" title=\"RITUXIMAB\" namespace=\"/drugs/rituximab\">RITUXIMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP93593\" title=\"OBINUTUZUMAB\" namespace=\"/drugs/obinutuzumab\">OBINUTUZUMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP97242\" title=\"ALEMTUZUMAB\" namespace=\"/drugs/alemtuzumab\">ALEMTUZUMAB</xref>\n</drugs>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugClasses\" href=\"#drugClasses\" namespace=\"/drug-classes\" title=\"Drug classes\" count=\"1\" rel=\"link\">Drug classes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP5660\" namespace=\"/drugs/ofatumumab\" title=\"OFATUMUMAB\" count=\"1\" rel=\"link\">OFATUMUMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP5662\" namespace=\"/drugs/rituximab\" title=\"RITUXIMAB\" count=\"1\" rel=\"link\">RITUXIMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP93593\" namespace=\"/drugs/obinutuzumab\" title=\"OBINUTUZUMAB\" count=\"1\" rel=\"link\">OBINUTUZUMAB</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP97242\" namespace=\"/drugs/alemtuzumab\" title=\"ALEMTUZUMAB\" count=\"1\" rel=\"link\">ALEMTUZUMAB</xref>\n</links>\n</topic>",
    "id": "PHP34582",
    "outputclass": "drugClass",
    "rev": "1.14",
    "type": "drugClass",
    "namespace": "/drug-classes/anti-lymphocyte-monoclonal-antibodies",
    "basename": "anti-lymphocyte-monoclonal-antibodies",
    "title": "ANTI-LYMPHOCYTE MONOCLONAL ANTIBODIES",
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "The anti-lymphocyte monoclonal antibodies cause lysis of B lymphocytes.",
                "html": "<p>The anti-lymphocyte monoclonal antibodies cause lysis of B lymphocytes.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "textContent": "All anti-lymphocyte monoclonal antibodies should be given under the supervision of an experienced specialist, in an environment where full resuscitation facilities are immediately available.",
                "html": "<p>All anti-lymphocyte monoclonal antibodies should be given under the supervision of an experienced specialist, in an environment where full resuscitation facilities are immediately available.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Allergic reactions",
                        "html": "Allergic reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "chills",
                        "html": "chills",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "cytokine release syndrome",
                        "html": "cytokine release syndrome",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "tumour pain",
                        "html": "tumour pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Cardiac events",
                        "html": "Cardiac events",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Infusion-related side-effects",
                "textContent": "In rare cases infusion reactions may be fatal.\n\nInfusion-related side-effects occur predominantly during the first infusion. Patients should receive premedication before administration of anti-lymphocyte monoclonal antibodies to reduce these effects&#8212;consult product literature for details of individual regimens.\n\nThe infusion may have to be stopped temporarily and the infusion-related effects treated&#8212;consult product literature for appropriate management.\n\nEvidence of pulmonary infiltration and features of tumour lysis syndrome should be sought if infusion-related effects occur.",
                "html": "<p>In rare cases infusion reactions may be fatal.</p><p>Infusion-related side-effects occur predominantly during the first infusion. Patients should receive premedication before administration of anti-lymphocyte monoclonal antibodies to reduce these effects&#8212;consult product literature for details of individual regimens.</p><p>The infusion may have to be stopped temporarily and the infusion-related effects treated&#8212;consult product literature for appropriate management.</p><p>Evidence of pulmonary infiltration and features of tumour lysis syndrome should be sought if infusion-related effects occur.</p>"
            },
            {
                "type": "advice",
                "title": "Cytokine release syndrome",
                "textContent": "Fatalities following severe cytokine release syndrome (characterised by severe dyspnoea) and associated with features of tumour lysis syndrome have occurred after infusions of anti-lymphocyte monoclonal antibodies. Patients with a high tumour burden as well as those with pulmonary insufficiency or infiltration are at increased risk and should be monitored very closely (and a slower rate of infusion considered).",
                "html": "<p>Fatalities following <b>severe</b> cytokine release syndrome (characterised by severe dyspnoea) and associated with features of tumour lysis syndrome have occurred after infusions of anti-lymphocyte monoclonal antibodies. Patients with a high tumour burden as well as those with pulmonary insufficiency or infiltration are at increased risk and should be monitored <b>very closely</b> (and a slower rate of infusion considered).</p>"
            }
        ]
    },
    "preTreatmentScreening": {
        "preTreatmentScreening": [
            {
                "type": "preTreatmentScreening",
                "textContent": "All patients should be screened for hepatitis B before treatment.",
                "html": "<p>All patients should be screened for hepatitis B before treatment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Patients should also be monitored for cytopenias&#8212;consult product literature for specific recommendations.",
                "html": "<p>Patients should also be monitored for cytopenias&#8212;consult product literature for specific recommendations.</p>"
            }
        ]
    },
    "drugsInClass": [
        {
            "id": "PHP5660",
            "label": "OFATUMUMAB",
            "type": "drug"
        },
        {
            "id": "PHP5662",
            "label": "RITUXIMAB",
            "type": "drug"
        },
        {
            "id": "PHP93593",
            "label": "OBINUTUZUMAB",
            "type": "drug"
        },
        {
            "id": "PHP97242",
            "label": "ALEMTUZUMAB",
            "type": "drug"
        }
    ],
    "backlinks": {},
    "links": {
        "#drugClasses": [
            {
                "id": "drugClasses",
                "label": "Drug classes",
                "type": "#drugClasses"
            }
        ],
        "drug": [
            {
                "id": "PHP5660",
                "label": "OFATUMUMAB",
                "type": "drug"
            },
            {
                "id": "PHP5662",
                "label": "RITUXIMAB",
                "type": "drug"
            },
            {
                "id": "PHP93593",
                "label": "OBINUTUZUMAB",
                "type": "drug"
            },
            {
                "id": "PHP97242",
                "label": "ALEMTUZUMAB",
                "type": "drug"
            }
        ]
    }
}